Clinical implications of the hemodynamic effects of beta blockade

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Beta-adrenoceptor blockade produces a well-established constellation of hemodynamic effects at rest and during exercise. The beneficial clinical response in patients with hypertension and angina pectoris relates directly to these hemodynamic effects. A number of molecular modifications have accomplished more selective or additional circulatory effects designed to improve the efficacy and reduce the adverse effects of these drugs. In considering further clinical application of these agents, new data relating to the role of the sympathetic nervous system in the response to exercise, in the control of heart rate and in the progression of the syndrome of heart failure must be considered.

Original languageEnglish (US)
Pages (from-to)D125-D128
JournalThe American Journal of Cardiology
Volume55
Issue number10
DOIs
StatePublished - Apr 26 1985

Fingerprint

Hemodynamics
Exercise
Sympathetic Nervous System
Angina Pectoris
Adrenergic Receptors
Heart Failure
Heart Rate
Hypertension
Pharmaceutical Preparations

Cite this

Clinical implications of the hemodynamic effects of beta blockade. / Cohn, Jay N.

In: The American Journal of Cardiology, Vol. 55, No. 10, 26.04.1985, p. D125-D128.

Research output: Contribution to journalArticle

@article{6054ecabde6940bfb0377c9bfb5ef424,
title = "Clinical implications of the hemodynamic effects of beta blockade",
abstract = "Beta-adrenoceptor blockade produces a well-established constellation of hemodynamic effects at rest and during exercise. The beneficial clinical response in patients with hypertension and angina pectoris relates directly to these hemodynamic effects. A number of molecular modifications have accomplished more selective or additional circulatory effects designed to improve the efficacy and reduce the adverse effects of these drugs. In considering further clinical application of these agents, new data relating to the role of the sympathetic nervous system in the response to exercise, in the control of heart rate and in the progression of the syndrome of heart failure must be considered.",
author = "Cohn, {Jay N.}",
year = "1985",
month = "4",
day = "26",
doi = "10.1016/0002-9149(85)91067-7",
language = "English (US)",
volume = "55",
pages = "D125--D128",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "10",

}

TY - JOUR

T1 - Clinical implications of the hemodynamic effects of beta blockade

AU - Cohn, Jay N.

PY - 1985/4/26

Y1 - 1985/4/26

N2 - Beta-adrenoceptor blockade produces a well-established constellation of hemodynamic effects at rest and during exercise. The beneficial clinical response in patients with hypertension and angina pectoris relates directly to these hemodynamic effects. A number of molecular modifications have accomplished more selective or additional circulatory effects designed to improve the efficacy and reduce the adverse effects of these drugs. In considering further clinical application of these agents, new data relating to the role of the sympathetic nervous system in the response to exercise, in the control of heart rate and in the progression of the syndrome of heart failure must be considered.

AB - Beta-adrenoceptor blockade produces a well-established constellation of hemodynamic effects at rest and during exercise. The beneficial clinical response in patients with hypertension and angina pectoris relates directly to these hemodynamic effects. A number of molecular modifications have accomplished more selective or additional circulatory effects designed to improve the efficacy and reduce the adverse effects of these drugs. In considering further clinical application of these agents, new data relating to the role of the sympathetic nervous system in the response to exercise, in the control of heart rate and in the progression of the syndrome of heart failure must be considered.

UR - http://www.scopus.com/inward/record.url?scp=0021830139&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021830139&partnerID=8YFLogxK

U2 - 10.1016/0002-9149(85)91067-7

DO - 10.1016/0002-9149(85)91067-7

M3 - Article

C2 - 2859790

AN - SCOPUS:0021830139

VL - 55

SP - D125-D128

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 10

ER -